We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+5.94%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$447B
AUM Growth
+$39.1B
Cap. Flow
-$684M
Cap. Flow %
-0.15%
Top 10 Hldgs %
27.16%
Holding
15,073
New
1,965
Increased
5,545
Reduced
5,814
Closed
1,500

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$877M
2
BKNG icon
Booking.com
BKNG
+$370M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$329M
4
BA icon
Boeing
BA
+$303M
5
WMT icon
Walmart Inc
WMT
+$291M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$544M
2
MBB icon
iShares MBS ETF
MBB
+$461M
3
NVDA icon
NVIDIA
NVDA
+$452M
4
TMUS icon
T-Mobile US
TMUS
+$426M
5
AAPL icon
Apple
AAPL
+$408M

Sector Composition

Rank Sector Weight
1 Technology 3.15%
2 Healthcare 3.06%
3 Financials 2.35%
4 Consumer Discretionary 2.28%
5 Industrials 1.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KOLD icon
8726
CALL
ProShares UltraShort Bloomberg Natural Gas
KOLD
$118M
$824K ﹤0.01%
4,030
+1,810
+82% +$582K
KURA icon
8727
Kura Oncology
KURA
$1.1B
$824K ﹤0.01%
39,505
-1,395,712
-97% -$34.7M
HAAC
8728
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$824K ﹤0.01%
82,280
-110,235
-57% -$1.12M
FRSX
8729
Foresight Autonomous Holdings
FRSX
$3.58M
$823K ﹤0.01%
1,538
+1,058
+220% +$606K
ARAV
8730
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
$823K ﹤0.01%
137,700
+125,800
+1,057% +$665K
CCCC icon
8731
CALL
C4 Therapeutics
CCCC
$514M
$821K ﹤0.01%
+21,700
New +$777K
GCO icon
8732
CALL
Genesco
GCO
$387M
$821K ﹤0.01%
12,900
+1,900
+17% +$103K
HOMZ icon
8733
Hoya Capital Housing ETF
HOMZ
$35.5M
$821K ﹤0.01%
+20,425
New +$817K
TRVG
8734
PUT
trivago
TRVG
$338M
$821K ﹤0.01%
49,600
-15,980
-24% -$295K
CUE icon
8735
PUT
Cue Biopharma
CUE
$175M
$820K ﹤0.01%
2,347
-2,233
-49% -$866K
TNC icon
8736
Tennant Co
TNC
$1.13B
$820K ﹤0.01%
10,263
-14,158
-58% -$1.16M
UGP icon
8737
Ultrapar
UGP
$6.75B
$820K ﹤0.01%
218,141
+114,916
+111% +$445K
SVSVW
8738
DELISTED
Spring Valley Acquisition Corp. Warrant
SVSVW
$820K ﹤0.01%
607,745
-186
-0% -$194
CELU icon
8739
Celularity
CELU
$21.3M
$819K ﹤0.01%
8,050
-23,333
-74% -$2.36M
IIIN icon
8740
Insteel Industries
IIIN
$620M
$819K ﹤0.01%
25,474
+8,340
+49% +$288K
JOBY icon
8741
PUT
Joby Aviation
JOBY
$7.57B
$819K ﹤0.01%
82,100
-196,000
-70% -$1.96M
SPOK icon
8742
Spok Holdings
SPOK
$229M
$819K ﹤0.01%
85,113
+62,816
+282% +$671K
MOND
8743
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
$819K ﹤0.01%
84,227
+394
+0.5% +$3.84K
CTLP
8744
DELISTED
Cantaloupe
CTLP
$818K ﹤0.01%
68,960
+24,658
+56% +$289K
WRI
8745
CALL
DELISTED
Weingarten Realty Investors
WRI
$818K ﹤0.01%
25,500
-33,900
-57% -$1.07M
ADC icon
8746
Agree Realty
ADC
$9.23B
$817K ﹤0.01%
11,592
-63,757
-85% -$4.47M
CMRE icon
8747
CALL
Costamare
CMRE
$1.8B
$817K ﹤0.01%
69,200
+30,500
+79% +$328K
LEG icon
8748
Leggett & Platt
LEG
$1.28B
$817K ﹤0.01%
15,767
-1,092
-6% -$56.8K
MRKR icon
8749
Marker Therapeutics
MRKR
$19.2M
$817K ﹤0.01%
29,303
+11,132
+61% +$293K
QED
8750
DELISTED
IQ Hedge Event-Driven Tracker ETF
QED
$817K ﹤0.01%
+34,185
New +$808K

Similar funds

Ken Griffin's Q2 2021 Portfolio in Review

As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.

By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.

  • Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
  • Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
  • Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
  • Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
  • Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
  • Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
  • Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.

Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.